Adults diagnosed with autism in the United Kingdom and Sweden today arrive with markedly different demographic and medical backgrounds from those diagnosed just over a decade ago, according to new research published in BMJ Mental Health. The study finds that first-time adult diagnoses have climbed fastest among young adults and women, overtaking male rates in recent years, while rising more slowly among ethnic minority and immigrant groups. Newly diagnosed adults are also less likely to have a history of intellectual disability or epilepsy and far more likely to have prior records of anxiety, depression or ADHD.
Autism is a neurodevelopmental condition marked by persistent challenges in social communication and by restricted, repetitive patterns of behaviour and interests. Across high‑income nations, clinical diagnoses have risen steadily over the past two decades, prompting questions about whether the condition itself is more common or whether clinicians are labeling it differently.
Earlier population studies have suggested that the surge in clinical records does not reflect a real increase in autistic traits. For example, a 2015 Swedish study found diagnoses in national registries rose even as autism symptom levels reported by parents remained stable. A UK cohort study from 2021 documented a near eightfold increase in new autism diagnoses between 1998 and 2018, with the steepest growth among women and adults rather than young boys.
Researchers offer competing explanations for this widening gap between stable population traits and rising diagnosis rates. Some experts argue greater public awareness, reduced stigma, and improved clinical training have helped clinicians recognise subtler presentations of autism in groups previously overlooked. A 2020 review highlighted how autistic girls and women may mask or compensate for social difficulties—a phenomenon known as camouflaging that can delay diagnosis until adulthood.
Delayed recognition may also coincide with accumulated mental health struggles. Earlier work comparing autistic adults by age of diagnosis indicated that those identified in adulthood tended to have higher rates of co‑occurring psychiatric conditions and suicidal thoughts than those diagnosed in childhood.
Another view in the medical literature is that diagnostic boundaries may have broadened beyond traditional thresholds. Some clinicians might attribute social difficulties to autism or use an autism label as a practical route to access scarce educational and social support for struggling individuals.
To clarify how adult diagnoses are shifting across different health systems, the study led by Aws Sadik of the University of Bristol analysed more than a decade of health records in the UK and Sweden. The researchers tracked how the demographic and psychiatric profiles of diagnosed adults have changed since 2010.
In the United Kingdom, electronic primary care records spanning 2010 to 2023 covered more than 24 million people aged 16 and older, including 141,119 with an autism diagnosis. In Sweden, researchers linked nationwide registries covering specialist outpatient clinics, hospital admissions and family socioeconomic data from 2010 to 2021, capturing about 9.1 million residents aged 16 and older, including 100,817 with an autism diagnosis.
Two autistic advisory researchers helped shape the study questions and define medical conditions before the project began, with a third reviewer also involved. The authors made their analytical code and diagnostic code lists publicly available online, and the team compared first-time adult diagnoses with the broader population of living autistic adults diagnosed at any time.
For each calendar year, the scientists assessed both adults receiving their first recorded autism diagnosis and the total population of living autistic adults, including those diagnosed in childhood. They used age standardisation to compare groups with different age structures between 16 and 65 years.
The UK dataset enabled analysis by sex, age band, ethnicity and neighbourhood socioeconomic deprivation. In Sweden, the study examined sex, age, parental birthplace, parental household income at birth and parental education, with parental analyses limited to adults aged 16 to 35 due to data constraints.
To evaluate medical histories, the researchers matched nearly every newly diagnosed autistic adult with up to four non-autistic adults of the same age, sex and local area, checking records prior to diagnosis for 15 neuropsychiatric conditions and seven classes of medications.
Across both countries, 38,858 adults in the UK and 50,239 in Sweden received a new autism diagnosis during the follow-up period. New adult diagnosis rates began much lower in the UK than in Sweden but accelerated rapidly after 2019 in Britain.
In the UK, first-time adult diagnoses rose more than tenfold from 0.6 per 10,000 person-years in 2010 to 6.4 in 2023, while in Sweden rates increased from 4.3 to 6.5 per 10,000 person-years between 2010 and 2021. Across both nations, 16 to 20-year-olds experienced the highest diagnosis rates and the fastest rises, with the overall prevalence in that age group reaching 4.1% by the end of the study period.
Sex patterns among new adult diagnoses shifted over time. Initially, men had higher rates, but by the end of the study period, women surpassed men in both countries. By 2023 in the UK, age‑standardised rates of new diagnoses reached 10.2 per 10,000 person‑years among women and 6.7 among men; in Sweden, 2021 figures stood at 9.4 for women versus 8.0 for men. Across all living autistic adults, total prevalence remained higher in men, though the female proportion narrowed in both countries.
Ethnicity and family migration history widens the diagnostic gap, especially among women. In the UK, diagnoses rose faster among white and mixed‑ethnicity groups than among Black or South Asian groups, while in Sweden, where parental birthplace was available only for younger adults, rates increased more for those with Swedish‑born parents. The researchers found that shifts in data completeness did not account for these widening gaps.
Socioeconomic patterns showed a mixed picture. In the UK, overall autism rates were higher in more deprived neighbourhoods, and in Sweden, higher rates appeared among adults whose parents had upper secondary education or higher, with parental income differences not statistically significant. Among newly diagnosed UK women, deprivation differences had diminished by 2023.
Alongside demographic shifts, the medical backgrounds of newly diagnosed adults moved away from severe cognitive and neurological conditions toward common mental health, sleep and pain disorders. Across both countries, prior records of intellectual disability, epilepsy or psychotic disorders declined, while prior anxiety, depression, ADHD, sleep disorders, eating disorders, PTSD and pain-related conditions became more common. Prescriptions for antidepressants, melatonin, opioids and gabapentinoids also rose in both nations, with larger absolute increases among autistic adults than among non-autistic comparators.
Similar patterns emerged when examining all living autistic adults, not just those newly diagnosed. In 2010, many conditions were more common in autistic women than men, and the study notes that anxiety, eating disorders and chronic fatigue grew fastest among autistic women in both countries, with sex differences widening more in the UK overall.
The authors remark that the 4.1% prevalence observed among 16 to 20-year-olds and the narrowing sex ratios diverge from general population surveys that typically estimate autism prevalence around 1% with a male-to-female ratio near 3.5 to 1. They propose that increases in mental health diagnoses across the population, updates to diagnostic manuals that encourage recognition of co‑occurring conditions, and better understanding of nuanced autism presentations may drive the observed shifts. They also caution that some presentations associated with camouflaging could be mislabelled as autism in some cases.
Interpreting these findings requires caution. Because the study relies on routine administrative records rather than direct clinical assessments, it cannot determine whether profile shifts reflect overdue recognition of subtle autism or broader diagnostic practices. Missing data and differences in data sources between the UK and Sweden may also influence the observed trends, and Swedish data do not extend beyond 2021.
Regardless of the underlying causes, the authors argue that health services must adapt to a changing clinical profile of adults seeking and living with an autism diagnosis. They advocate moving away from isolated assessments aimed solely at confirming autism, towards integrated clinical teams capable of addressing overlapping mental health needs while further research investigates why ethnic minority and immigrant communities face growing gaps in diagnosis.
The study—titled Changes in the profile of adults diagnosed as autistic since 2010: population-based studies in the UK and Sweden—was authored by Aws Sadik, Michael Lundberg, Golam M Khandaker, Antonio F Pardiñas, Brian K Lee, Paul Madley‑Dowd, Cecilia Magnusson and Dheeraj Rai.
